Newsroom | 5757 results

CHATTANOOGA, Tenn.--(BUSINESS WIRE)--Unum Group’s (NYSE: UNM) President & CEO, Rick McKenney will represent the company at the KBW Insurance Conference. McKenney is scheduled to speak at the conference at 2:05 p.m. ET on Wednesday, September 9, 2026. He will discuss the company’s business strategy and future growth prospects. A live audio webcast of the presentation will be available on the Investors section of Unum’s website, www.investors.unum.com, on the News and Events page. ABOUT UNUM...

GENEVA--(BUSINESS WIRE)--Alcon Prices EUR 500 Million Senior Notes Offering...

ALPHARETTA, Ga.--(BUSINESS WIRE)--National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) today announced that the Company is scheduled to present at the Barclays 19th Annual Global Consumer Conference on Wednesday, September 9, 2026, at 12:45 p.m. Eastern Time. A live webcast of the presentation will be available in the “Investors” section of the Company’s website at www.ir.nationalvision.com. The webcast will be archived and available on the website shortly after the...

STUART, Fla.--(BUSINESS WIRE)--Stuart Therapeutics, Inc. (“Stuart”), a late-stage biopharmaceutical company developing first-in-class collagen-reparative therapeutics to treat eye diseases, today announced the appointment of Dave LeCause as senior commercial advisor. LeCause will lead the company's commercial strategy as Stuart advances its lead therapeutic candidate, ST-100 for dry eye disease. ST-100 is expected to begin Phase 3b clinical trials in the first quarter of 2027. LeCause joins Stu...

DURHAM, N.C.--(BUSINESS WIRE)--Based on the company’s leading ophthalmology EHR and PM solution, Sightview has launched a platform for ophthalmologists with user-favorite workflows....

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that two of its pharmaceutical pipeline assets – both first-in-class treatments – will advance to new trials based on recent clinical results. “Helping people see better to live better starts with tackling the challenges patients still face every day,” said Bausch + Lomb CEO Brent Saunders. “These results suppor...

BOSTON & SAN FRANCISCO--(BUSINESS WIRE)--Eyebot, the automated vision test kiosk that provides doctor-verified eyeglass prescriptions, today announced a strategic partnership with QUAY, the global eyewear brand known for on-trend design and premium materials at an attainable price point. Through the first-of-its-kind partnership, combining innovative technology with fashion, Eyebot's automated vision test kiosk is now available inside select QUAY retail stores, allowing customers to receive a d...

WATERTOWN, Mass.--(BUSINESS WIRE)--Ingenia Therapeutics, a clinical-stage biotechnology company pioneering next-generation vascular-targeted therapies, today announced that it has been nominated for the Prix Galien USA and the inaugural Prix Galien Korea, both in the Best Startup category by The Galien Foundation. The Galien Foundation is the premier global institution recognizing and awarding outstanding achievements of innovators in life sciences. The dual recognition arrives alongside a defi...

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced that its management is scheduled to participate in the Wells Fargo Healthcare Conference on Wednesday, September 9, 2026, at 3:00 p.m. ET in Boston, MA. A live and archived webcast for these events, where applicable, will be available in the Investors...

BOSTON--(BUSINESS WIRE)--Ora, the world's leading ophthalmic contract research organization, appoints retina specialist Dr. John Trein as Therapeutic Lead, Posterior...